OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
June 01, 2012
Legislation to reauthorize Food and Drug Administration user fee programs sailed through the House and Senate last month, setting the stage for leading legislators to resolve their differences and agree on a compromise measure.
May 02, 2012
Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
April 02, 2012
Soaring opioid use creates challenges for new drug development and supply-chain control.
March 02, 2012
Social media use raises questions about applying old standards to new information technology.
February 09, 2012
After months of anticipation, the Food and Drug Administration issued guidances last month that outlines its recommendations for developing and approving biosimilar therapies.
February 02, 2012
More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.